Paclitaxel eluting stents for the treatment of angiographically non‐significant atherosclerotic lesions

References

• Gruntzig A. R., Senning A., Siegenthaler W. E. Nonoperative dilatation of coronary‐artery stenosis: percutaneous transluminal coronary angioplasty. N Engl J Med 1979; 301: 61–8
   PubMed Web of Science ®Google Scholar
• Yusuf S., Reddy S., Ounpuu S., Anand S. Global burden of cardiovascular diseases: Part II: variations in cardiovascular disease by specific ethnic groups and geographic regions and prevention strategies. Circulation 2001; 104: 2855–64
   PubMed Web of Science ®Google Scholar
• Virmani R., Kolodgie F. D., Burke A. P., Farb A., Schwartz S. M. Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol 2000; 20: 1262–75
   PubMed Web of Science ®Google Scholar
• Virmani R., Burke A. P., Farb A. Sudden cardiac death. Cardiovasc Pathol 2001; 10: 211–8
   PubMed Web of Science ®Google Scholar
• Burke A. P., Kolodgie F. D., Farb A. Healed plaque ruptures and sudden coronary death: evidence that subclinical rupture has a role in plaque progression. Circulation 2001; 103: 934–40
   PubMed Web of Science ®Google Scholar
• Smith S. C, Jr., Dove J. T., Jacobs A. K. ACC/AHA guidelines for percutaneous coronary intervention (revision of the 1993 PTCA guidelines)‐executive summary: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee to revise the 1993 guidelines for percutaneous transluminal coronary angioplasty) endorsed by the Society for Cardiac Angiography and Interventions. Circulation 2001; 103: 3019–41
   PubMed Web of Science ®Google Scholar
• Davies M. J., Richardson P. D., Woolf N., Katz D. R., Mann J. Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophage, and smooth muscle cell content. Br Heart J 1993; 69: 377–81
   PubMedGoogle Scholar
• Gertz S. D., Roberts W. C. Hemodynamic shear force in rupture of coronary arterial atherosclerotic plaques. Am J Cardiol 1990; 66: 1368–72
   PubMed Web of Science ®Google Scholar
• Smits P. C., Pasterkamp G., Quarles van Ufford M. A. Coronary artery disease: arterial remodelling and clinical presentation. Heart 1999; 82: 461–4
   PubMed Web of Science ®Google Scholar
• Morice M. C., Serruys P. W., Sousa J. E. A randomized comparison of a sirolimus‐eluting stent with a standard stent for coronary revascularization. N Engl J Med 2002; 346: 1773–80
   PubMed Web of Science ®Google Scholar
• Degertekin M., Serruys P. W., Foley D. P. Persistent inhibition of neointimal hyperplasia after sirolimus‐eluting stent implantation: long‐term (up to 2 years) clinical, angiographic, and intravascular ultrasound follow‐up. Circulation 2002; 106: 1610–3
   PubMed Web of Science ®Google Scholar
• Hoye A., Lemos P. A., Arampatzis C. A. Effectiveness of sirolimus‐Eluting stent implantation for coronary narrowings <50% in diameter. Am J Cardiol 2004; 94: 112–4
   PubMed Web of Science ®Google Scholar
• Ischinger T., Gruentzig A. R., Hollman J. Should coronary arteries with less than 60% diameter stenosis be treated by angioplasty?. Circulation 1983; 68: 148–54
   PubMedGoogle Scholar
• Ellis S., Alderman E., Cain K., Fisher L., Sanders W., Bourassa M. Prediction of risk of anterior myocardial infarction by lesion severity and measurement method of stenoses in the left anterior descending coronary distribution: a CASS Registry Study. J Am Coll Cardiol 1988; 11: 908–16
   PubMed Web of Science ®Google Scholar
• Mercado N., Maier W., Boersma E. Clinical and angiographic outcome of patients with mild coronary lesions treated with balloon angioplasty or coronary stenting. Implications for mechanical plaque sealing. Eur Heart J 2003; 24: 541–51
   PubMed Web of Science ®Google Scholar
• Hamon M., Bauters C., McFadden E. P., Lablanche J. M., Bertrand M. E. Six‐month quantitative angiographic follow‐up of <50% diameter stenoses dilated during multilesion percutaneous transluminal coronary angioplasty. Am J Cardiol 1993; 71: 1226–9
   PubMed Web of Science ®Google Scholar
• Kong D. F., Califf R. M., Miller D. P. Clinical outcomes of therapeutic agents that block the platelet glycoprotein IIb/IIIa integrin in ischemic heart disease. Circulation 1998; 98: 2829–35
   PubMed Web of Science ®Google Scholar
• Anderson K. M., Califf R. M., Stone G. W. Long‐term mortality benefit with abciximab in patients undergoing percutaneous coronary intervention. J Am Coll Cardiol 2001; 37: 2059–65
   PubMed Web of Science ®Google Scholar
• Abizaid A. S., Mintz G. S., Mehran R. Long‐term follow‐up after percutaneous transluminal coronary angioplasty was not performed based on intravascular ultrasound findings: importance of lumen dimensions. Circulation 1999; 100: 256–61
   PubMed Web of Science ®Google Scholar
• Bech G. J., De Bruyne B., Pijls N. H. Fractional flow reserve to determine the appropriateness of angioplasty in moderate coronary stenosis: a randomized trial. Circulation 2001; 103: 2928–34
   PubMed Web of Science ®Google Scholar
• van der Wal A. C., Becker A. E., van der Loos C. M., Das P. K. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation 1994; 89: 36–44
   PubMed Web of Science ®Google Scholar
• Moreno P. R., Falk E., Palacios I. F., Newell J. B., Fuster V., Fallon J. T. Macrophage infiltration in acute coronary syndromes. Implications for plaque rupture. Circulation 1994; 90: 775–8
   PubMed Web of Science ®Google Scholar
• Kolodgie F. D., Burke A. P., Farb A. The thin‐cap fibroatheroma: a type of vulnerable plaque: the major precursor lesion to acute coronary syndromes. Curr Opin Cardiol 2001; 16: 285–92
   PubMed Web of Science ®Google Scholar
• Jang I. K., Bouma B. E., Kang D. H. Visualization of coronary atherosclerotic plaques in patients using optical coherence tomography: comparison with intravascular ultrasound. J Am Coll Cardiol 2002; 39: 604–9
   PubMed Web of Science ®Google Scholar
• Moreno P. R., Muller J. E. Detection of high‐risk atherosclerotic coronary plaques by intravascular spectroscopy. J Interv Cardiol 2003; 16: 243–252
   PubMedGoogle Scholar
• Schaar J. A., De Korte C. L., Mastik F., Strijder C., Pasterkamp G., Boersma E., Serruys P. W., Van Der Steen A. F. Characterizing vulnerable plaque features with intravascular elastography. Circulation 2003; 108: 2636–41
   PubMed Web of Science ®Google Scholar
• Nair A., Kuban B. D., Tuzcu E. M., Schoenhagen P., Nissen S. E., Vince D. G. Coronary plaque classification with intravascular ultrasound radiofrequency data analysis. Circulation 2002; 106: 2200–6
   PubMed Web of Science ®Google Scholar
• Schaar J. A., Muller J. E., Falk E. Terminology for high‐risk and vulnerable coronary artery plaques. Report of a meeting on the vulnerable plaque, June 17 and 18, 2003, Santorini, Greece. Eur Heart J 2004; 25: 1077–82
   PubMed Web of Science ®Google Scholar